Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Dynamic computer models of xenobiotics].

D Rothley1, H Oelschläger

  • 1Institut für Pharmazeutische Chemie der Johann Wolfgang Goethe-Universität Frankfurt am Main, BRD.

Die Pharmazie
|February 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Markov-modeling for the administration of platinum analogues and paclitaxel as first-line chemotherapy as well as topotecan and liposomal doxorubicin as second-line chemotherapy with epithelial ovarian carcinoma.

Journal of cancer research and clinical oncology·2007
Same author

[In vitro investigations of phase I metabolism of the fomocaine derivative Oe 9000 with pig liver homogenates].

Die Pharmazie·2006
Same author

[Studies on the recovery of pharmaceutical drug substances from surfaces made of defined stainless-steel alloys].

Die Pharmazie·2005
Same author

Investigations on the thermal behavior of omeprazole and other sulfoxides.

Die Pharmazie·2005
Same author

Investigations of interactions of chlormezanone racemate and its enantiomers on human keratinocytes and human leucoytes in vitro.

Skin pharmacology and physiology·2005
Same author

[Simultaneous photometric determination of covalently bound fluorine and fluoride ion contamination adsorbed on drugs in the low ppm range after alkaline pulping].

Die Pharmazie·2004

A dynamic pharmacokinetic model simulates xenobiotic transport and distribution in the body. This computational method captures complex biological systems for studying drug kinetics.

Area of Science:

  • Pharmacokinetics and computational biology.
  • Biomedical modeling and simulation.
  • Drug transport and metabolism studies.

Context:

  • Understanding xenobiotic behavior in biological systems is crucial for drug development and toxicology.
  • Existing pharmacokinetic models often simplify complex physiological processes.
  • There is a need for dynamic models that capture spatio-temporal variations in substance distribution.

Purpose:

  • To develop a dynamic pharmacokinetic model (DVM) based on physical substance transport in the circulatory system.
  • To simulate the behavior of xenobiotics and their metabolites through direct, discrete-step algorithms.
  • To represent the cardiovascular system and other kinetic components as multi-dimensional arrays for detailed analysis.

Summary:

Related Experiment Videos

  • The developed dynamic pharmacokinetic model (DVM) simulates xenobiotic and metabolite transport and distribution in blood and tissues using discrete steps.
  • It employs multi-dimensional arrays to represent the cardiovascular system and other kinetic areas (transport, storage, distribution, exchange, reaction).
  • The model accounts for biochemical transformations by introducing separate array sets for each metabolite, offering a flexible tool for kinetic process studies.

    • Impact:

    • Provides a highly flexible tool for studying kinetic processes with a great variety of coefficients.
    • The model's time- and position-dependent discrete substance distribution reflects biological system heterogeneity and complexity.
    • This dynamic pharmacokinetic model encompasses compartmental models as a subset, offering a more comprehensive approach.